Yunhao Zhai

Yunhao Zhai

Auto-generated profile, based on publicly available information

Yunhao Zhai

Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Cell Reports
Verified
Journal Article
Open access
JCJavier Celis-Gutierrez
Javier Celis-Gutierrez
PBPeter Blattmann
Peter Blattmann
YZYunhao Zhai
Yunhao Zhai
NJNicolas Jarmuzynski
Nicolas Jarmuzynski
KRKilian Ruminski
Kilian Ruminski
BMBernard Malissen
Bernard Malissen
Deciphering how TCR signals are modulated by coinhibitory receptors is of fundamental and clinical interest. Using quantitative interactomics, we define the composition and dynamics of the PD-1 and BTLA coinhibitory signalosomes in primary effector T cells and at the T cell-antigen-presenting cell interface. We also solve the existing controversy regarding the role of the SHP-1 and SHP-2 protein-tyrosine phosphatases in mediating PD-1 coinhibition. PD-1 predominantly recruits SHP-2, but when absent, it recruits SHP-1 and remains functional. In contrast, BTLA predominantly recruits SHP-1 and to a lesser extent SHP-2. By separately analyzing the PD-1-SHP-1 and PD-1-SHP-2 complexes, we show that both dampen the TCR and CD28 signaling pathways equally. Therefore, our study illustrates how comparison of coinhibitory receptor signaling via quantitative interactomics in primary T cells unveils their extent of redundancy and provides a rationale for designing combinations of blocking antibodies in cancer immunotherapy on the basis of undisputed modes of action.

19 January 2024 in Applied Physics Reviews
Verified
Journal Article
Open access
PDF file
NJNicholas Jeffreys
Nicholas Jeffreys
JBJoshua M. Brockman
Joshua M. Brockman
YZYunhao Zhai
Yunhao Zhai
DIDonald E Ingber
Donald E Ingber
DMDavid J. Mooney
David J. Mooney
Adoptive T cell immunotherapies, including engineered T cell receptor (eTCR) and chimeric antigen receptor (CAR) T cell immunotherapies, have shown efficacy in treating a subset of hematologic malignancies, exhibit promise in solid tumors, and have many other potential applications, such as in fibrosis, autoimmunity, and regenerative medicine. While immunoengineering has focused on designing biomaterials to present biochemical cues to manipulate T cells ex vivo and in vivo, mechanical cues that regulate their biology have been largely underappreciated. This review highlights the contributions of mechanical force to several receptor–ligand interactions critical to T cell function, with central focus on the TCR–peptide-loaded major histocompatibility complex (pMHC). We then emphasize the role of mechanical forces in (i) allosteric strengthening of the TCR–pMHC interaction in amplifying ligand discrimination during T cell antigen recognition prior to activation and (ii) T cell interactions with the extracellular matrix. We then describe approaches to design eTCRs, CARs, and biomaterials to exploit TCR mechanosensitivity in order to potentiate T cell manufacturing and function in adoptive T cell immunotherapy.

27 March 2018 in Cell Research
Verified
Journal Article
Closed access
PDF file
FYFang Yu
Fang Yu
GSGuang Shi
Guang Shi
SCShimeng Cheng
Shimeng Cheng
JCJiwei Chen
Jiwei Chen
SWShwu-Yuan Wu
Shwu-Yuan Wu
JWJiemin Wong
Jiemin Wong

2 November 2020 in Cellular & Molecular Immunology
Verified
Journal Article
Open access
PDF file
YZYunhao Zhai
Yunhao Zhai
JCJavier Celis-Gutierrez
Javier Celis-Gutierrez
GVGuillaume Voisinne
Guillaume Voisinne
DMDaiki Mori
Daiki Mori
LGLaura Girard
Laura Girard
BMBernard Malissen
Bernard Malissen

11 March 2026 in Nature Biomedical Engineering
Verified
Journal Article
Open access
PDF file
YZYang C. Zeng
Yang C. Zeng
OYOlivia J. Young
Olivia J. Young
QXQiancheng Xiong
Qiancheng Xiong
LSLonglong Si
Longlong Si
MKMin Wen Ku
Min Wen Ku
WSWilliam M. Shih
William M. Shih
Current SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccines have shown robust induction of neutralizing antibodies and CD4 + T cell activation; however, CD8 + responses are variable, and the duration of immunity and protection against variants are limited. Here we repurpose our DNA origami vaccine nanotechnology DoriVac to target infectious viruses, namely, SARS-CoV-2, HIV and Ebola. The DNA origami nanoparticle, conjugated with infectious-disease-specific heptad repeat 2 peptides, which act as highly conserved antigens, and CpG adjuvant at precise nanoscale spacing, induces neutralizing antibodies, Th1 CD4 + T cells and CD8 + T cells in naive mice, with significant improvement over a bolus control. Pre-clinical studies using lymph-node-on-a-chip systems validate that DoriVac, when conjugated with antigenic peptides or proteins, induces promising cellular and humoral immune responses in human cells. Moreover, DoriVac bearing full-length SARS-CoV-2 spike protein achieves immune responses comparable to current mRNA vaccine platforms while potentially reducing storage constraints. These results suggest that DoriVac holds potential as a versatile, modular vaccine platform, capable of inducing both humoral and cellular immunities, underscoring its potential future use.

30 January 2026 in Bone Research
Verified
Journal Article
Open access
MDMengmeng Duan
Mengmeng Duan
CZChenchen Zhou
Chenchen Zhou
GSGuanyue Su
Guanyue Su
CZChunhe Zhang
Chunhe Zhang
JRJie Ren
Jie Ren
JXJing Xie
Jing Xie
Cells actively sense and transduce microenvironmental mechanical inputs into chemical signals via cytoskeletal rearrangements. During these mechanosensation and mechanotransduction processes, the role of the actin cytoskeleton is well-understood, whereas the role of the tubulin cytoskeleton remains largely elusive. Here, we report the dynamic changes in microtubules in response to microenvironmental stiffness during chondrocyte mitosis. Mechanical stiffness was found to be coupled with microtubule generation, directing microtubule dynamics in mitotic chondrocytes. Refilin B was found to be a key regulator of microtubule assembly in chondrocytes in response to mechanical stiffness. It was found to play its role in microtubule formation via the p-Smad3 signaling pathway. Additionally, integrin-linked kinase (ILK), triggered by mechanical stiffness, was found to play an indispensable role in the process of microtubule dynamics mediated by refilin B. Our data emphasizes stiffness-mediated dynamic changes in the microtubules of chondrocytes in a quiescent state (G0) and at anaphase, which improves our understanding of the mechanical regulation of microtubule assembly during the chondrocyte cell cycle and provides insights into microenvironment mechanics during tissue maintenance, wound healing, and disease occurrence.